3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, B-Cell
2
Leukemia, Myeloid, Acute
2
Sarcoma, Ewing
1
Lymphoproliferative Disorders
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Interventions
Nivolumab
25
Specimen Handling
19
cabozantinib
15
pembrolizumab
13
Magnetic Resonance Spectroscopy
13
Ipilimumab
13
belzutifan
12
lenvatinib
7
CTLA-4 Antigen
7
Biopsy
7
Axitinib
7
atezolizumab
4
Sunitinib
4
tivozanib
3
Surveys and Questionnaires
3
Immunoglobulin G
3
Everolimus
3
Disulfides
3
zimberelimab
2
relatlimab
2
pazopanib
2
palbociclib
2
aldesleukin
2
X-Rays
2
Watchful Waiting
2
Standard of Care
2
Radiosurgery
2
Practice Guidelines as Topic
2
Nephrectomy
2
Bevacizumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Renal Cell
×
etoposide phosphate
×
30 days
×
Clear all
No trials found.